BENO TNR, Inc.
KKRX:206400680.00
KRW
+61.00
(+9.85%)
ISIN
KR7206400004
Return %
Stock
S&P 500
1Y
-69.91
14.39
3Y
-86.21
81.42
5Y
-87.41
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Jib-Hun Jeong
- Full Time Employees
- 21
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Seoul South Korea
- IPO Date
- Dec 10, 2014
- Website
- benotnr.com
- Similar Companies
- Business
- BENO TNR, Inc. is a South Korea-based diversified company primarily engaged in the development and provision of eco-friendly building solutions, interior architectural systems, wearable healthcare robotics, and biotechnology research. Founded in 2001 and headquartered in Seoul, South Korea, the company operates across multiple specialized business segments providing an integrated portfolio of products and services: architectural interior and building engineering solutions, including motorized interior and exterior sun-shading systems, automated roll screens, architectural louvers, radiant heating and cooling ceiling panels, eco-friendly raised access flooring systems, and HVAC ventilation duct systems; medical robotics and mobility devices, featuring the XoMotion-R self-balancing wearable exoskeleton designed for lower-limb mobility assistance, neurological rehabilitation, and clinical physical therapy; biopharmaceutical development through its Benobio division, focusing on epigenetic therapeutic modifications, novel drug candidate discovery, and life science investments; and digital software solutions, encompassing smart media platforms, connected device middleware, and artificial intelligence software systems. The company serves public institutions, commercial property developers, general contractors, hospitals, rehabilitation centers, and enterprise clients across South Korea, North America, and Southeast Asia. In recent developments, the company changed its corporate name from Beno Holdings, Inc. to BENO TNR, Inc. to reflect its strategic pivot toward advanced technologies. BENO TNR has accelerated its expansion into medical robotics through its subsidiaries Human in Motion Robotics and Human in Motion Robotics Asia, securing medical device licensing from Health Canada for its flagship XoMotion-R robotic exoskeleton while progressing clinical evaluations for U.S. Food and Drug Administration (FDA) and South Korea Ministry of Food and Drug Safety (MFDS) clearances. To augment its technology stack, the company executed a strategic investment and acquisition in software developer Alticast Corporation to integrate artificial intelligence capabilities with robotic hardware, formed a commercial distribution partnership with Singapore-based healthcare company Robotimize to drive market expansion across the ASEAN region, and acquired the duct manufacturing business division of Kumyoung ENC to scale its building materials operations.